## Core Concept
Akathisia is a type of extrapyramidal side effect (EPS) characterized by subjective feelings of restlessness and an urge to move, often manifesting as fidgeting or pacing. It is commonly associated with the use of antipsychotic medications, particularly first-generation (typical) antipsychotics. The treatment involves managing these symptoms to improve patient comfort and compliance with medication.

## Why the Correct Answer is Right
The correct answer, . (Propranolol), is a beta-blocker that has been widely used to treat akathisia. Propranolol's effectiveness in akathisia is thought to be related to its ability to block peripheral beta-adrenergic receptors, which may contribute to the symptoms of akathisia. It is often considered a first-line treatment for this condition due to its efficacy and relatively favorable side effect profile.

## Why Each Wrong Option is Incorrect
- **Option A:** - This option is incorrect because, although anticholinergics can treat some types of EPS like parkinsonism, they are not typically effective for akathisia and can sometimes even exacerbate it.
- **Option B:** - This option is incorrect as there is no commonly recognized treatment for akathisia by this name or class in this context, making it an implausible choice.
- **Option D:** - This option is incorrect because, while benzodiazepines can provide symptomatic relief for some patients with akathisia, they are generally considered second-line treatments due to their potential for dependence and other side effects.

## Clinical Pearl / High-Yield Fact
A key point to remember is that akathisia can significantly impact a patient's quality of life and adherence to antipsychotic medication. Early recognition and treatment are crucial. Propranolol is a useful option, but clinicians should also consider adjusting the antipsychotic regimen if possible.

## Correct Answer Line
**Correct Answer: . Propranolol**